InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Jayne David R.W.. Officer active across 1 company, notably Aurinia Pharmaceuticals Inc.. Cumulatively, 6 filings have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €117k. History available since 18 May 2022. The latest transaction was disclosed on 21 November 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Jayne David R.W. is a declarant and Director of Aurinia Pharmaceuticals Inc. (XNAS). There are 6 filings in total, and across the sampled recent filings from 2022-07-11 to 2024-11-25, the reported buys are 0 EUR and the reported sells are 117459 EUR, with the modal transaction nature shown as Attribution.